Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intermediate cell markers for malignancy. Consistency of expression.

G L Wied, M Bibbo, F T Pishotta

    Analytical and Quantitative Cytology
    |December 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A PC-based system for the objective analysis of histologic specimens through quantitative contextual karyometry.

    Applied optics·2010
    Same author

    Knowledge engineering in quantitative histopathology.

    Applied optics·2010
    Same author

    Study of viral integration of HPV-16 in young patients with LSIL.

    Journal of clinical pathology·2003
    Same author

    Processing liquid-based gynecologic specimens: comparison of the available techniques.

    Acta cytologica·2001
    Same author

    Expression of cytokeratin 20 and CD44 protein in upper urinary tract transitional cell carcinoma: cytologic-histologic correlation.

    Analytical and quantitative cytology and histology·2001
    Same author

    Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver.

    Cancer·2001

    This study found that specific markers consistently indicate abnormal cervical cytology in patients. However, the absence of these markers does not completely rule out uterine abnormalities, suggesting further research is needed.

    Area of Science:

    • Gynecologic pathology
    • Cervical cancer screening

    Background:

    • Cervical cancer screening relies on accurate detection of abnormal cytology.
    • Previously identified markers showed promise in detecting malignancy.

    Purpose of the Study:

    • To confirm the consistency of malignancy markers in normal-appearing intermediate cervical cells from patients with abnormal cytology.
    • To evaluate the diagnostic utility of these markers in cervical cancer prescreening.

    Main Methods:

    • Analysis of cervical cell samples from patients with confirmed abnormal cytology (moderate dysplasia, severe dysplasia/carcinoma in situ).
    • Assessment of the expression of previously reported malignancy markers in normal-appearing intermediate cells.

    Main Results:

    Related Experiment Videos

  • Consistent expression of malignancy markers was confirmed in samples from patients with abnormal cervical cytology.
  • A false-negative rate of 10% to 30% was estimated with small sample sizes (30 cells/case).
  • Marker expression reliably indicates abnormal cytology, but lack of expression does not exclude abnormalities.

    • Conclusions:

    • Marker feature studies are valuable for indicating abnormal uterine cytology.
    • Larger sample sizes and improved staining protocols could enhance the utility of these markers for cancer prescreening.